Harvard Bioscience Inc. Schedules First Quarter 2012 Conference Call for May 3, 2012

HOLLISTON, Mass., April 30, 2012 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer and marketer of a broad range of specialized products used to advance life science research and regenerative medicine, will announce results for the first quarter ended March 31, 2012 before market trading hours on Thursday, May 3, 2012.
MORE ON THIS TOPIC